Keros Therapeutics logo
Keros Therapeutics KROS
$ 55.79 3.62%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Keros Therapeutics EV - Enterprise Value 2011-2024 | KROS

Annual EV - Enterprise Value Keros Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.72 B 1.24 B 1.15 B 975 M -1.63 M 14.7 M - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.72 B -1.63 M 850 M